Research Frontiers Incorporated
REFR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 46.8% | 68.5% | -57.3% | – |
| Cost of Goods Sold | $0 | $2 | $0 | $0 |
| Gross Profit | $1 | -$1 | $1 | $1 |
| % Margin | 80.3% | -159.4% | 100% | 100% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $0 | $3 | $3 |
| Operating Expenses | $3 | $1 | $3 | $3 |
| Operating Income | -$1 | -$2 | -$3 | -$2 |
| % Margin | -108% | -223.5% | -486.4% | -145.6% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$2 | -$3 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$2 | -$3 | -$2 |
| % Margin | -98.2% | -209.8% | -494.6% | -146.2% |
| EPS | -0.039 | -0.057 | -0.083 | -0.058 |
| % Growth | 31.4% | 31.5% | -42.7% | – |
| EPS Diluted | -0.039 | -0.057 | -0.083 | -0.058 |
| Weighted Avg Shares Out | 34 | 33 | 32 | 32 |
| Weighted Avg Shares Out Dil | 34 | 33 | 32 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$2 | -$2 |
| % Margin | -88.2% | -204.6% | -454% | -131.6% |